KAMBIZ ZANDI-NEJAD, M.D.
Osteopathic Medicine at Brookline Ave, Boston, MA

License number
Massachusetts 208281
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
133 Brookline Ave, Boston, MA 02215
Phone
(617) 421-1126
(617) 421-1066 (Fax)

Personal information

See more information about KAMBIZ ZANDI-NEJAD at radaris.com
Name
Address
Phone
Kambiz Zandi-Nejad
Brookline, MA
(617) 734-1812
Kambiz Zandi-Nejad
20 Chapel St #B512, Brookline, MA 02446
(617) 734-1812
Kambiz Zandi-Nejad
276 Chestnut Hill Ave, Brighton, MA 02135

Organization information

See more information about KAMBIZ ZANDI-NEJAD at bizstanding.com

Kambiz Zandi-Nejad MD

75 Francis St, Boston, MA 02115

Industry:
Internist
Site:
Phone:
(617) 732-6020 (Phone)
Description:
There are 23 doctors at this site. Surgery is not performed at this site.
Kambiz Zandi-Nejad


Kambiz Zandi-Nejad MD

133 Brookline Ave, Boston, MA 02215

Categories:
Physicians & Surgeons
Phone:
(617) 509-8000 (Phone)

Professional information

Kambiz Zandi-Nejad Photo 1

Dr. Kambiz Zandi-Nejad - MD (Doctor of Medicine)

Hospitals:
133 Brookline Ave, Boston 02215
Brigham and Women's Hospital NEP
75 Francis St, Boston 02115
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
Newton - Wellesley Hospital
2014 Washington St, Newton 02462
133 Brookline Ave, Boston 02215
Brigham and Women's Hospital NEP
75 Francis St, Boston 02115
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
Newton - Wellesley Hospital
2014 Washington St, Newton 02462
Education:
Medical Schools
Tehran School Of Medical Sciences
Graduated: 1990


Kambiz Zandi-Nejad Photo 2

Monocarboxylates For Modifying Macrophage Function

US Patent:
2009024, Oct 1, 2009
Filed:
Sep 12, 2007
Appl. No.:
12/310971
Inventors:
Kambiz Zandi-Nejad - Brighton MA, US
Anil Chandraker - Westwood MA, US
Joseph Bonventre - Wayland MA, US
David Mount - Newton MA, US
Assignee:
The Brigham and Women's Hospital, Inc. - Boston MA
International Classification:
A61K 31/455, C12N 5/06, A61P 3/10, A61P 37/06
US Classification:
514356, 435375
Abstract:
The present invention is directed to methods of inhibiting the production of proinflammatory agents by macrophages by contacting the cells with a monocarboxylate such as nicotinic acid. The invention also includes methods of treating diseases that are associated with macrophage activation such as atherosclerosis; systemic lupus erythematosus; rheumatoid arthritis; inflammatory bowel disease; and diabetes mellitus.